Company QuantaMatrix Inc.

Equities

A317690

KR7317690006

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-02 EDT			5-day change	1st Jan Change
4,140 ^KRW	+1.72%		+9.81%	-11.16%

03-08	QuantaMatrix Inc. announced that it has received KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	CI
03-07	QuantaMatrix Inc. announced that it expects to receive KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	CI

QuantaMatrix Inc is a Korean-based company engaged in the development and production of in vitro diagnostics (IVD) medical devices. The Company's main products include a multi-diagnostic unique test platform, micro disc, antimicrobial susceptibility testing sepsis diagnostic equipment, molecular immunity diagnosis automation platform, rapid antituberculosis susceptibility testing equipment, rapid antituberculosis susceptibility testing kits, and others. In addition, the Company sells covid kits and engages in research and development of microbial diagnostic products.

KRW in Million	2022	Weight	2023	Weight	Delta
Medical Devices 100.0 %	1,286	100.0 %	3,118	100.0 %	+142.47%

KRW in Million	2022	Weight	2023	Weight	Delta
Europe 83.1 %	861	67.0 %	2,590	83.1 %	+200.70%
Middle East 11.0 %	208	16.2 %	342	11.0 %	+64.55%
South Korea 6.0 %	217	16.8 %	186	6.0 %	-14.28%

Managers	Title	Age	Since
Sung-Hoon Kwon FOU	Founder	49	10-11-28
Jae-Hoon Kwon DFI	Director of Finance/CFO	47	-
Dong-Young Kim CTO	Chief Tech/Sci/R&D Officer	49	-
Jae-Hyun Kwon AUD	Comptroller/Controller/Auditor	52	-

Members of the board	Title	Age	Since
Won-Hee Seol BRD	Director/Board Member	62	-
Sung-Hoon Kwon FOU	Founder	49	10-11-28
Jae-Hoon Kwon DFI	Director of Finance/CFO	47	-
Dong-Young Kim CTO	Chief Tech/Sci/R&D Officer	49	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	16,537,411	10,587,162 ( 64.02 %)	0	64.02 %

Name	Equities	%	Valuation
The Ezrah Charitable Trust 19.70 %	3,258,393	19.70 %	10 M ₩
Sung-Hoon Kwon 13.50 %	2,232,920	13.50 %	7 M ₩
Dong-Young Kim 1.209 %	200,000	1.209 %	618 012 ₩
Ye-won Jung 0.6692 %	110,668	0.6692 %	341 971 ₩
Jae-Hoon Kwon 0.5977 %	98,852	0.5977 %	305 459 ₩
Soon-im Jeon 0.2988 %	49,416	0.2988 %	152 698 ₩
Tiger Asset Management Investment Co. Ltd. 0.000000 %	0	0.000000 %	- ₩

QuantaMatrix, Inc.

16/F B1 BYC Hi city 131 Gasan Digital 1-ro

08506, Seoul

http://www.quantamatrix.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
QUANTAMATRIX INC.	-11.16%	49.12M
BIOMÉRIEUX	-1.89%	12.5B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.67B
LANTHEUS HOLDINGS, INC.	+21.82%	5.36B
DIASORIN S.P.A.	-1.31%	5.26B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-50.89%	3.15B
ANDON HEALTH CO., LTD.	+6.42%	2.59B
VITROLIFE AB	-10.02%	2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B

Diagnostic & Testing Substances